CVRX
CVRx, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-51/100
Last price
1.56
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.52
Prev close
1.56
Day high
1.69
Day low
1.54
Volume
537.12K
Market cap
$43.16M
P/E (TTM)
—
52W range
1.50 – 11.30
Day trading desk
Gap from prior close
-2.58%
Prior close 1.56
VWAP
1.64
-4.80% from price
Relative volume
0.57×
Quiet session
Session range
11.21%
1.52 – 1.69
Position in range
24%
Near session low
ATR (14D)
0.24
15.68% of price
Prior day high
1.62
PDH
Prior day low
1.50
PDL
Bid / ask spread
—
Quote not published
Session volume
510.56K
Avg 903.09K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-38.40%
-40.4%
1M
-46.89%
-48.0%
3M
-69.26%
-73.8%
6M
-80.65%
-98.8%
YTD
-77.18%
-91.4%
1Y
-81.40%
-97.8%
3Y
-89.32%
-171.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CVRX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+106.24K
Net buying
Buy transactions
8
107.55K shares
Sell transactions
1
1.31K shares
Net transactions
+9
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
2.75M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 13, 26 | BINKOWSKI BRENT Chief Operating Officer |
BUY | 26.22K | $76.43K | Direct |
| Aug 12, 26 | BINKOWSKI BRENT Chief Operating Officer |
SELL | 1.31K | $3.34K | Direct |
| Jun 1, 26 | SLATTERY JOSEPH P Director |
STOCK | 8.72K | $0 | Direct |
| Jun 1, 26 | DALE MICHAEL D Director |
STOCK | 29.00K | $0 | Direct |
| Jun 1, 26 | HILL MITCH C Director |
STOCK | 8.72K | $0 | Direct |
| Jun 1, 26 | BALLINGER KEVIN J Director |
STOCK | 8.72K | $0 | Direct |
| Jun 1, 26 | JAIN MUDIT KUMAR Director |
STOCK | 8.72K | $0 | Direct |
| Jun 1, 26 | NIELSEN KIRK G Director |
STOCK | 8.72K | $0 | Direct |
| Jun 1, 26 | SHADAN MARTHA Director |
STOCK | 8.72K | $0 | Direct |
| Mar 2, 26 | HYKES KEVIN Chief Executive Officer |
SELL | 7.76K | $61.35K | Direct |
| Mar 2, 26 | VERRASTRO PAUL Officer |
SELL | 1.28K | $10.15K | Direct |
| Mar 2, 26 | OASHEIM JARED Chief Financial Officer |
SELL | 1.74K | $13.78K | Direct |
| Mar 2, 26 | JOHN ROBERT ALLEN Officer |
SELL | 3.96K | $31.33K | Direct |
| Mar 2, 26 | ADAMSON PHILIP B. Officer |
SELL | 1.26K | $9.97K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ADAMSON PHILIP B. |
Officer | 61.58K | Sale |
HYKES KEVIN |
Chief Executive Officer | 284.24K | Sale |
JAIN MUDIT KUMAR |
Director | 994.55K | Stock Award(Grant) |
JOHN ROBERT ALLEN |
Officer | 86.04K | Sale |
JOHNSON & JOHNSON |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
JOHNSON & JOHNSON DEVELOPMENT CORPORATION |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
JOHNSON & JOHNSON INNOVATION - JJDC, INC. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
NIELSEN KIRK G |
Director | 1.92M | Stock Award(Grant) |
OASHEIM JARED |
Chief Financial Officer | 96.70K | Sale |
VERRASTRO PAUL |
Officer | 60.55K | Sale |
Fundamentals
Market cap$43.16M
Enterprise value$37.96M
Revenue (TTM)$61.19M
Gross profit$53.18M
EBITDA$-47.84M
Net income$-51.97M
EPS (TTM)$-1.97
Free cash flow$-23.80M
Total cash$64.59M
Total debt$59.39M
Book value / share$0.75
Shares outstanding26.64M
Float18.31M
Short % of float8.64%
Dividend yield0.00%
Beta (5Y)0.77
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.86
PEG ratio—
Price / sales—
Price / book2.16
EV / revenue0.62
EV / EBITDA-0.79
Gross margin86.92%
Operating margin-82.92%
Profit margin-84.93%
Return on equity-133.45%
Return on assets-28.70%
Debt / equity297.65
Current ratio8.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $56.65M | $51.29M | $39.30M | $22.47M | +10.4% |
| Operating revenue | $56.65M | $51.29M | $39.30M | $22.47M | +10.4% |
| Cost of revenue | $8.31M | $8.33M | $6.26M | $5.00M | -0.3% |
| Gross profit | $48.34M | $42.96M | $33.04M | $17.47M | +12.5% |
| Research & development | $11.13M | $11.13M | $11.63M | $9.95M | +0.0% |
| Selling, general & admin | $88.47M | $91.32M | $64.51M | $50.05M | -3.1% |
| Total operating expense | $99.61M | $102.45M | $76.14M | $60.00M | -2.8% |
| Operating income | -$51.27M | -$59.49M | -$43.10M | -$42.53M | +13.8% |
| Net interest income | -$5.83M | -$4.40M | -$1.80M | -$165.00K | -32.5% |
| Pre-tax income | -$53.32M | -$59.91M | -$41.05M | -$41.32M | +11.0% |
| Tax provision | -$18.00K | $55.00K | $147.00K | $109.00K | -132.7% |
| Net income | -$53.31M | -$59.97M | -$41.20M | -$41.43M | +11.1% |
| Net income to common | -$53.31M | -$59.97M | -$41.20M | -$41.43M | +11.1% |
| Basic EPS | -2.04 | -2.65 | -1.99 | -2.02 | +23.0% |
| Diluted EPS | -2.04 | -2.65 | -1.99 | -2.02 | +23.0% |
| EBIT | -$47.50M | -$55.51M | -$39.25M | -$41.15M | +14.4% |
| EBITDA | -$46.74M | -$54.89M | -$38.73M | -$40.74M | +14.9% |
| Basic shares | 26.08M | 22.60M | 20.75M | 20.53M | +15.4% |
| Diluted shares | 26.08M | 22.60M | 20.75M | 20.53M | +15.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $75.71M | $105.93M | $90.57M | $106.19M | -28.5% |
| Cash & short-term investments | $75.71M | $105.93M | $90.57M | $106.19M | -28.5% |
| Accounts receivable | $10.66M | $9.27M | $7.55M | $5.50M | +15.1% |
| Inventory | $12.21M | $12.11M | $10.98M | $6.96M | +0.8% |
| Total current assets | $101.65M | $129.81M | $112.09M | $122.88M | -21.7% |
| Property, plant & equipment | $3.12M | $3.57M | $3.11M | $2.03M | -12.7% |
| Total assets | $104.79M | $133.41M | $115.23M | $124.94M | -21.5% |
| Total current liabilities | $13.32M | $10.76M | $7.86M | $8.09M | +23.7% |
| Long-term debt | $49.51M | $49.27M | $29.22M | $6.75M | +0.5% |
| Total debt | $50.50M | $50.43M | $30.61M | $7.09M | +0.1% |
| Total liabilities | $65.47M | $62.36M | $39.28M | $15.76M | +5.0% |
| Retained earnings | -$590.65M | -$537.35M | -$477.38M | -$436.18M | -9.9% |
| Shareholder equity | $39.32M | $71.06M | $75.95M | $109.18M | -44.7% |
| Working capital | $88.33M | $119.05M | $104.23M | $114.79M | -25.8% |
| Net tangible assets | $39.32M | $71.06M | $75.95M | $109.18M | -44.7% |
| Shares issued | 26.31M | 25.32M | 20.88M | 20.63M | +3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$53.31M | -$59.97M | -$41.20M | -$41.43M | — | +11.1% |
| Depreciation & amortisation | $756.00K | $619.00K | $522.00K | $412.00K | — | +22.1% |
| Stock-based compensation | $11.05M | $19.05M | $6.30M | $3.89M | — | -42.0% |
| Change in working capital | $1.00M | $949.00K | -$4.80M | -$5.57M | — | +5.5% |
| Operating cash flow | -$40.17M | -$39.14M | -$39.02M | -$42.68M | — | -2.6% |
| Capital expenditure | -$580.00K | -$1.36M | -$591.00K | -$685.00K | — | +57.4% |
| Investing cash flow | -$580.00K | -$1.36M | -$591.00K | -$685.00K | — | +57.4% |
| Share buybacks | — | — | — | $0 | -$1.00K | — |
| Financing cash flow | $10.52M | $55.87M | $23.98M | $7.49M | — | -81.2% |
| Free cash flow | -$40.75M | -$40.51M | -$39.61M | -$43.36M | — | -0.6% |
| End cash position | $75.71M | $105.93M | $90.57M | $106.19M | — | -28.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $15.71M | $14.77M | $16.02M | $14.69M | $13.59M | +6.3% |
| Operating revenue | $15.71M | $14.77M | $16.02M | $14.69M | $13.59M | +6.3% |
| Cost of revenue | $1.98M | $1.89M | $2.20M | $1.94M | $2.14M | +4.9% |
| Gross profit | $13.72M | $12.88M | $13.82M | $12.75M | $11.45M | +6.5% |
| Research & development | $3.13M | $3.08M | $3.00M | $3.15M | $2.47M | +1.5% |
| Selling, general & admin | $23.62M | $21.96M | $22.01M | $21.88M | $23.36M | +7.6% |
| Total operating expense | $26.75M | $25.04M | $25.01M | $25.02M | $25.83M | +6.8% |
| Operating income | -$13.02M | -$12.16M | -$11.18M | -$12.27M | -$14.38M | -7.1% |
| Net interest income | -$1.58M | -$1.55M | -$1.42M | -$1.48M | -$1.47M | -1.7% |
| Pre-tax income | -$14.04M | -$13.12M | -$11.94M | -$12.87M | -$14.74M | -7.0% |
| Tax provision | $3.00K | $1.00K | -$7.00K | -$3.00K | -$3.00K | +200.0% |
| Net income | -$14.04M | -$13.12M | -$11.93M | -$12.87M | -$14.74M | -7.0% |
| Net income to common | -$14.04M | -$13.12M | -$11.93M | -$12.87M | -$14.74M | -7.0% |
| Basic EPS | -0.53 | -0.50 | -0.46 | -0.49 | -0.57 | -6.0% |
| Diluted EPS | -0.53 | -0.50 | -0.46 | -0.49 | -0.57 | -6.0% |
| EBIT | -$12.46M | -$11.57M | -$10.52M | -$11.39M | -$13.27M | -7.7% |
| EBITDA | -$12.25M | -$11.36M | -$10.34M | -$11.20M | -$13.07M | -7.8% |
| Basic shares | 26.52M | 26.36M | 26.22M | 26.17M | 26.07M | +0.6% |
| Diluted shares | 26.52M | 26.36M | 26.22M | 26.17M | 26.07M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $64.59M | $72.30M | $75.71M | $85.12M | $95.03M | -10.7% |
| Cash & short-term investments | $64.59M | $72.30M | $75.71M | $85.12M | $95.03M | -10.7% |
| Accounts receivable | $9.40M | $9.10M | $10.66M | $8.21M | $7.15M | +3.3% |
| Inventory | $13.03M | $12.40M | $12.21M | $11.39M | $11.72M | +5.0% |
| Total current assets | $89.49M | $96.75M | $101.65M | $107.89M | $116.14M | -7.5% |
| Property, plant & equipment | $2.77M | $2.95M | $3.12M | $3.41M | $3.39M | -6.2% |
| Total assets | $92.28M | $99.73M | $104.79M | $111.33M | $119.56M | -7.5% |
| Total current liabilities | $11.12M | $9.49M | $13.32M | $11.22M | $9.69M | +17.3% |
| Long-term debt | $58.57M | $58.49M | $49.51M | $49.45M | $49.39M | +0.1% |
| Total debt | $59.39M | $59.40M | $50.50M | $50.52M | $50.54M | -0.0% |
| Total liabilities | $72.33M | $70.62M | $65.47M | $63.27M | $61.63M | +2.4% |
| Retained earnings | -$617.82M | -$603.77M | -$590.65M | -$578.72M | -$565.85M | -2.3% |
| Shareholder equity | $19.95M | $29.11M | $39.32M | $48.05M | $57.93M | -31.5% |
| Working capital | $78.36M | $87.26M | $88.33M | $96.67M | $106.46M | -10.2% |
| Net tangible assets | $19.95M | $29.11M | $39.32M | $48.05M | $57.93M | -31.5% |
| Shares issued | 26.64M | 26.43M | 26.31M | 26.19M | 26.15M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$14.04M | -$13.12M | -$11.93M | -$12.87M | -$14.74M | -7.0% |
| Depreciation & amortisation | $209.00K | $205.00K | $185.00K | $194.00K | $193.00K | +2.0% |
| Stock-based compensation | $3.67M | $2.92M | $2.79M | $2.89M | $2.92M | +25.7% |
| Change in working capital | $1.26M | -$2.25M | -$949.00K | $18.00K | $3.63M | +156.0% |
| Operating cash flow | -$8.83M | -$12.16M | -$9.76M | -$9.71M | -$7.94M | +27.4% |
| Capital expenditure | -$112.00K | -$122.00K | -$68.00K | -$295.00K | -$103.00K | +8.2% |
| Investing cash flow | -$112.00K | -$122.00K | -$68.00K | -$295.00K | -$103.00K | +8.2% |
| Share buybacks | — | -$43.00K | — | — | — | — |
| Financing cash flow | $1.22M | $8.88M | $410.00K | $103.00K | $392.00K | -86.3% |
| Free cash flow | -$8.94M | -$12.29M | -$9.83M | -$10.00M | -$8.04M | +27.3% |
| End cash position | $64.59M | $72.30M | $75.71M | $85.12M | $95.03M | -10.7% |
Options analytics
Put / call volume
0.10
Call-heavy session
Put / call open interest
5.00
Positioning, not flow
Max pain
5.00
+208.6% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
-50.0%
Calls bid over puts
Call volume
219
Contracts, this expiry
Put volume
21
Contracts, this expiry
Heaviest call OI
10.00
2 contracts
Heaviest put OI
5.00
10 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.52 | -0.53 | -1.2% |
| Mar 2026 | -0.50 | -0.50 | +0.8% |
| Dec 2025 | -0.44 | -0.46 | -4.9% |
| Sep 2025 | -0.50 | -0.49 | +2.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.50 | 5 | $13.91M | -5.3% |
| Next quarter | -0.49 | 5 | $14.43M | -10.0% |
| Current year | -2.02 | 5 | $58.85M | +3.9% |
| Next year | -1.88 | 7 | $66.18M | +12.5% |
Analyst targets & ownership
Mean target$4.58
High target$6.00
Low target$3.50
Implied upside193.80%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 3
Hold3
Sell / Strong sell0 / 1
Held by insiders10.33%
Held by institutions65.82%
Institutions holding127
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.12
-26.35% from price
SMA 20
2.53
-36.06% from price
SMA 50
3.15
-48.60% from price
SMA 100
4.26
-63.41% from price
SMA 200
5.83
-72.21% from price
EMA 12
2.11
-26.08% from price
EMA 26
2.55
-38.76% from price
EMA 50
3.13
-50.22% from price
RSI (14)
24.8
Oversold
MACD (12,26,9)
-0.44
Hist -0.10
ATR (14)
0.24
15.10% of price
Realised vol 30D
131.3%
Annualised
Bollinger upper
3.65
20, 2σ
Bollinger lower
1.42
20, 2σ
50 / 200 cross
Death
3.15 vs 5.83
Trend bias
Below 200
-72.21%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.87
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
131.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-85.8%
Peak to trough
Max drawdown 5Y
-95.4%
Peak to trough
ATR 14
0.24
15.10% of price
Beta (reported)
0.77
5Y monthly, from filing
Short interest
Shares short
1.64M
Prior 2.36M
Change vs prior
-30.3%
Shorts covering
% of float
8.64%
Normal
% of shares out
6.17%
Against total outstanding
Days to cover
2.2
Liquid
Float
18.31M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Aug 8, 26 | Lake Street | DOWNGRADE | Buy | Hold |
| Apr 14, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 13, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Nov 6, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Nov 6, 25 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Aug 5, 25 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| May 9, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| May 9, 25 | JP Morgan | DOWNGRADE | Neutral | Underweight |
| Apr 8, 25 | Lake Street | MAINTAINED | Buy | Buy |
| Apr 8, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 5, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-08-11
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-06-03
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Periodic Financial Reports
10-Q · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-11
Headlines
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
GlobeNewswire · 7d ago
Nyxoah Names Loic Moreau Interim CFO as John Landry Steps Down
MT Newswires · 15d ago
CVRx Names New Chief Financial Officer
MT Newswires · 15d ago
CVRx Appoints John Landry as Chief Financial Officer
GlobeNewswire · 15d ago
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
Zacks · 20d ago
CVRx Secures Devoted Health Coverage for Barostim Therapy
Zacks · 40d ago
CVRx Responds to Letter from Pointillist Family Office
GlobeNewswire · 43d ago
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
GlobeNewswire · 44d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.